DHL Supply Chain has announced the expansion of its specialized logistics services for the life sciences and healthcare sector in France through a strategic partnership with Sanofi. This collaboration will involve warehousing, inventory management, picking and packing, and order fulfillment
AugustBio is investing $65 million to expand its manufacturing facility in Nashville, Tennessee. This project aims to enhance the company’s capacity and capabilities in contract manufacturing. The new facility will include state-of-the-art equipment and additional space for production and development.
EUROAPI has been chosen by the European Commission as one of the 13 companies eligible to share up to €1 billion in public funding under the Important Project of Common European Interest (IPCEI) Med4Cure. The program, notified by six EU
RevOpsis Therapeutics and Kemwell Biopharma Pvt. Ltd. have entered a strategic partnership to accelerate the development of RevOpsis’ lead candidate, RO-104, for the treatment of neovascular age-related macular degeneration (nAMD). The collaboration, announced on June 17, 2024, leverages Kemwell’s contract
This video summarises the five key digital strategies for innovative, regulatory-friendly and data-savvy Decentralised Clinical Trials. Download the full ebook.
Lotte Biologics and Merck have entered a strategic partnership, formalised through a Letter of Intent (LOI) signed on June 14, 2024. The agreement focuses on biopharmaceutical manufacturing and process development. The signing ceremony featured key executives, including Richard Lee, CEO
UK Biocentre is a respected leader in sample management, high-capacity bioprocessing & analysis, and automated storage. With the capacity to store 35 million individual sample, it is the main processor for many of the UK’s government genetics projects, including the
Great Point Partners has made a strategic acquisition of Lyocontract, a private German contract development and manufacturing organization (CDMO). The announcement was made on Thursday, marking a significant move for the healthcare investment firm. Lyocontract, based in Ilsenburg, Germany, has been
Suven Pharmaceuticals has announced a strategic investment in Sapala Organics, a Hyderabad-based Contract Development and Manufacturing Organisation (CDMO) specialising in Oligo drugs and nucleic acid building blocks. The agreement is subject to regulatory approvals and conditions. Sapala Organics is a key
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
